Gefitinib in advanced breast cancer

被引：0
|
作者：
Rebecca Doherty
机构：
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncponc0270
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：484 / 485
页数：1
相关论文
共 50 条
  • [21] Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?
    Normanno, N
    Campiglio, M
    Perrone, F
    De Luca, A
    Menard, S
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1709 - 1709
  • [22] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [23] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [24] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
  • [25] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
  • [26] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    LANCET, 2008, 372 (9652): : 1785 - 1786
  • [27] Locally advanced breast cancer
    Barni, Sandro
    Mandala, Mario
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (01) : 47 - 52
  • [28] Locally advanced breast cancer
    Esteva, FJ
    Hortobagyi, GN
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (02) : 457 - +
  • [29] Exemestane in advanced breast cancer
    Buzdar, A
    ANTI-CANCER DRUGS, 2000, 11 (08) : 609 - 616
  • [30] Dalpiciclib in advanced breast cancer
    Chen, Xiaosong
    Shen, Kunwei
    LANCET ONCOLOGY, 2023, 24 (06): : 578 - 579
12345